阿特珠单抗 T9902

Product Introduction
Bioactivity


英文名: Atezolizumab

描述: Atezolizumab 是一种人源化单克隆抗体 IgG1，能抵抗程序性死亡因子配体1 ，可用于癌症研究。

细胞实验: Objective: Determine the binding of [111In]PD-L1-mAb to tumor cell lines. Cells: NCI-H2444（Lung Cancer cell line）, MDAMB231（Breast Cancer cell line）,etc. Concentrations: 1 μCi/100μl. Incubation Time: 1 h. Method: Incubating 1 μCi of [111In]PD-L1-mAb with 1×106cells (in triplicate for each cell line) for 1h at 37°C. PD-L1 blocking was performed by adding a 10-fold molar equivalent excess of the non-labeled mAb. After incubation, cells were washed three times with cold PBS prior to counting on an automated gamma counter.

存储条件: store at low temperaturestore at -20°C

关键字: Inhibitor | MPDL3280A | inhibit | Apoptosis | Atezolizumab | Autophagy

相关产品: JNJ-7706621 | physalin F | Nimustine Hydrochloride | UCF 101 | AZA1 | Sophoraflavanone G | Antitumor agent-115 | MG 149 | Dinaciclib | TPEN

阿特珠单抗 T9902信息由TargetMol中国为您提供，如您想了解更多关于阿特珠单抗 T9902报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途